Khurram Jamil - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Khurram Jamil has filed 4 SEC Form 4 filings across 1 company in the last 90 days - selling. Lifetime open-market sales: $1.45M.
Profile
Khurram Jamil is a corporate insider at GALECTIN THERAPEUTICS INC (GALT). Jamil has reported 13 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
Board memberships
- GALECTIN THERAPEUTICS INC
Trading Pattern
InsiderAlpha's records for Khurram Jamil go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 46 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Khurram Jamil has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT) - 10 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-16 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 16.2K | $5.13 | $83K |
| 2026-07-16 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 16.2K | $3.04 | $49K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 47.5K | $5.04 | $239K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 47.5K | $2.50 | $119K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 2.5K | $5.00 | $13K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 2.5K | $2.50 | $6K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 2.0K | $5.00 | $10K |
| 2026-06-30 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 2.0K | $2.20 | $4K |
| 2026-06-25 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 7.6K | $3.14 | $24K |
| 2026-06-25 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 7.6K | $1.23 | $9K |
| 2026-05-28 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 568 | $3.10 | $2K |
| 2026-05-28 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 568 | $1.23 | $699 |
| 2026-01-06 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 21.4K | $3.65 | $78K |
| 2026-01-06 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 25.5K | $3.90 | $99K |
| 2026-01-06 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 13.1K | $4.20 | $55K |
| 2026-01-06 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 60.0K | $0.00 | |
| 2026-01-05 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 8.1K | $4.07 | $33K |
| 2026-01-05 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 8.1K | $1.23 | $10K |
| 2025-12-19 | GALT | GALECTIN THERAPEUTICS INC | S - Open-market sale [10b5-1] | 8.5K | $7.04 | $60K |
| 2025-12-19 | GALT | GALECTIN THERAPEUTICS INC | M - Option exercise [10b5-1] | 8.5K | $2.50 | $21K |
Companies - Last 90 Days
- GALECTIN THERAPEUTICS INC (GALT) - 4 filings, last 2026-07-16
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Khurram Jamil has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.43M of GALT open-market activity in the last 12 months
- Jack W. Callicutt - $1.00M of GALT open-market activity in the last 12 months
- Joel Lewis - $710K of GALT open-market activity in the last 12 months
- Harold H. Shlevin - $501K of GALT open-market activity in the last 12 months
- Kevin D. Freeman - $20K of GALT open-market activity in the last 12 months
- Kary Eldred - $3K of GALT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- James M. Kilts
- Richard D. Kinder
- Steven B. Klinsky
- Adam Koppel
- Kenneth Krogulski
- L1 Capital Pty Ltd
- LAZARUS ENERGY HOLDINGS, LLC
- Sang Young Lee
Frequently Asked Questions
Who is Khurram Jamil?
Khurram Jamil is a corporate insider at GALECTIN THERAPEUTICS INC (GALT). Jamil has reported 13 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Khurram Jamil submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Khurram Jamil been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($1.45M) across all tracked filings.
Where can I see all of Khurram Jamil's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Khurram Jamil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.